Skip to main content
Caplight Logo









Kno2

Kno2

Private
Boise, IdahoHealthcare & Life Scienceshttps://kno2.com

Last Round

Series A

Jul 14, 2021

Total Funding Raised

$15M

Company Overview

Kno2 operates in Healthcare & Life Sciences and is based in Boise, Idaho. Its latest recorded funding round was a Series A round in July 2021.

Kno2 is a healthcare technology company that provides a cloud-based communication and interoperability platform for the secure exchange of clinical information.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Data Integration, API Management

Business Model

B2B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Kno2 Comparables

Compare Kno2 with similar companies based on industry and business-model similarity.

Kno2 comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Particle Health
90%
Health Gorilla
84%
Redox
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Kno2 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 14, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jon Elwell

CEO

Executive Team

For institutional investors. Book with your work email.

Kno2 Investors

Notable investors and investment history

Kno2 investors
InvestorRounds
Health Enterprise PartnersSeries A
Allumia VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    Attended CMS Health Technology Ecosystem national showcase.

  • Apr 3, 2026

    Alan Swenson appointed Chief of Staff and SVP of Network Strategy.

Book a demo to see all signals

For institutional investors. Book with your work email.

Kno2 Filings

Explore SEC and related filing metadata, where available.

Kno2 filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Kno2's valuation, stock price, and market status.

Is Kno2 a public or private company?

Kno2 is a private company.

What is the current stock price of Kno2?

Kno2 is a private company, so its shares have no public market price. Caplight tracks Kno2's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Kno2 worth (valuation)?

Valuation information for Kno2 is not publicly available.

Can I buy Kno2 stock?

Kno2 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Kno2's last funding round?

Kno2's most recent funding round was Series A on July 14, 2021.

Who are the main investors in Kno2?

Key investors in Kno2 include Health Enterprise Partners, Allumia Ventures.

Will Kno2 IPO soon?

No public IPO plans have been announced for Kno2.

How can I track Kno2 secondary market activity?

Caplight tracks bids, offers, and trades in Kno2's shares on secondary markets.

Firmographic Details

HeadquartersBoise, Idaho
Employee Range39
Year Founded2009
Last FundingJul 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?